Loading...

Aromatase inhibitors and their future role in post-menopausal women with early breast cancer.

Anastrozole is the first aromatase inhibitor to show a significant survival advantage over megestrol acetate in post-menopausal women with advanced breast cancer. The rationale for extending the use of aromatase inhibitors to the treatment of early breast cancer is based on the efficacy observed in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Hovedforfatter: Lønning, P. E.
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group|1 1998
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2062757/
https://ncbi.nlm.nih.gov/pubmed/9741783
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!